Position in PLX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$93,200
+$6,400 QoQ
Shares Held
40,000
0.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 101 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Phoenix Financial Ltd. holds $16,652,062 across 6 Biotechnology names. PLX ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLGL |
Sol-Gel Technologies Ltd.
|
146,147 | $10,835,338 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,993 | $2,976,902 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
47,403 | $1,481,817 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,109 | $691,505 | |
| 5 | MDWD |
MediWound Ltd.
|
39,000 | $573,300 | |
| 6 | PLX |
Protalix BioTherapeutics, Inc.
This page
|
40,000 | $93,200 |
All Filings in PLX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,200 | 40,000 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $86,800 | 40,000 | Shares | Defined | 2026-05-11 | |
| 2022-03-31 | $258,759 | 244,113 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $202,613 | 244,113 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $324,670 | 244,113 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $466,255 | 244,113 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,088,743 | 244,113 | Shares | Sole | 2021-05-10 | |
| 2020-09-30 | $790,853 | 204,355 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $713,793 | 188,336 | Shares | Sole | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||